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Constitutive c‐Jun N‐terminal kinase (JNK) activity characterizes bovine T and B cells
infected with Theileria parva, and B cells and macrophages infected with Theileria
annulata. Here, we show that T. annulata infection of macrophages manipulates JNK
activation by recruiting JNK2 and not JNK1 to the parasite surface, whereas JNK1
is found predominantly in the host cell nucleus. At the parasite's surface, JNK2 forms
a complex with p104, a GPI‐(GlycosylPhosphatidylInositol)‐anchor T. annulata plasma
membrane protein. Sequestration of JNK2 depended on Protein Kinase‐A (PKA)‐
mediated phosphorylation of a JNK‐binding motif common to T. parva and a cell pen-
etrating peptide harbouring the conserved p104 JNK‐binding motif competitively
ablated binding, whereupon liberated JNK2 became ubiquitinated and degraded.
Cytosolic sequestration of JNK2 suppressed small mitochondrial ARF‐mediated
autophagy, whereas it sustained nuclear JNK1 levels, c‐Jun phosphorylation, and
matrigel traversal. Therefore, T. annulata sequestration of JNK2 contributes to both
survival and dissemination of Theileria‐transformed macrophages.
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In mammals c‐Jun N‐terminal kinase (JNK) is encoded by three
genes, mapk8, mapk9, and mapk10; mapk8 and mapk9 code,wileyonlinelibrary.comrespectively, for the ubiquitously expressed JNK1 and JNK2 pro-
teins and mapk 10 codes for JNK3, whose expression is restricted
to cardiac, nervous, and testicular tissues (Davis, 2000). JNKs are
activated by environmental stress including extracellular insults such
as radiation, redox, osmotic and temperature shocks, and intracellu-
lar stress such as misfolded proteins (Davis, 2000). Biological© 2018 John Wiley & Sons Ltd/journal/cmi 1 of 12
2 of 12 LATRÉ DE LATÉ ET AL.responses transduced through JNK‐dependent pathways encompass
proliferation, migration, survival, differentiation, and inflammation
(Davis, 2000), and some of the JNK substrates participating in these
processes have been identified (Bogoyevitch & Kobe, 2006).
Changes in gene expression resulting from JNK activation may be
accounted for by the phosphorylation of several transcription fac-
tors and the ensuing alteration in their transcriptional activity
(Bogoyevitch & Kobe, 2006). A well‐characterized substrate of JNK
is c‐Jun, a component of the AP‐1 transcription factor that is essen-
tial for proliferation and cell survival. JNK can affect c‐Jun both pos-
itively and negatively: N‐terminal phosphorylated c‐Jun displays
increased trans‐activating activity (Hibi, Lin, Smeal, Minden, & Karin,
1993), whereas in neurons, the E3 ubiquitin ligase SCFFbw7 specifi-
cally targets phosphorylated c‐Jun for proteasome degradation,
thereby controlling the JNK/c‐Jun apoptotic pathway (Nateri,
Riera‐Sans, Da Costa, & Behrens, 2004). Additionally, in T lympho-
cytes, c‐Jun turnover is regulated by the E3 ubiquitin ligase Itch,
whose activity increases upon JNK‐dependent phosphorylation
(Gao et al., 2004). JNK can promote cell motility via alteration of
focal adhesion dynamics following JNK‐mediated phosphorylation
of the focal adhesion adaptor paxillin (Huang, Rajfur, Borchers,
Schaller, & Jacobson, 2003; Ueno et al., 2015; Wang et al., 2013).
Importantly, loss of jnk2 in mouse embryonic fibroblasts increases
cell proliferation, whereas a loss of jnk1 leads to decreased prolifera-
tion, and these contrasting effects are attributed to differential
regulation of the mitogenic transcription factor c‐Jun. JNK1 increases
c‐Jun stability via phosphorylation of serine 73, whereas JNK2
decreases c‐Jun stability by promoting its ubiquitination (Bode &
Dong, 2007; Fuchs, Dolan, Davis, & Ronai, 1996). JNK2 also promotes
ubiquitination‐dependent proteasomal degradation of small mitochon-
drial ARF (smARF), as in jnk2−/− mouse embryonic fibroblasts levels
of smARF rise to induce autophagy (Budina‐Kolomets, Hontz, Pimkina,
& Murphy, 2013; Zhang et al., 2015a). SmARF is a short isoform of
the tumour suppressor p19ARF, and interestingly, suppression of
smARF did not require the kinase activity of JNK2 to be consistent
with JNK2 acting as a scaffold protein (Zhang et al., 2015b). The above
examples highlight the disparate functions of JNK isoforms and
underscore the necessity to study them individually and together to
properly grasp the cellular impact of JNK activation.
Parasites of the genus Theileria are intracellular protozoans
belonging to the Apicomplexa phylum. Theileria annulata and Theileria
parva are two particularly pathogenic species that cause bovine
lymphoproliferative diseases, respectively named tropical theileriosis
and the East Coast Fever. The target host cells of T. parva are T and
B lymphocytes, whereas monocytes/macrophages and B cells are
preferentially infected by T. annulata. East Coast Fever and tropical
theileriosis display similarities to human lymphomas and myeloid
leukemias, respectively. A vaccine exists to tropical theileriosis based
on T. annulata‐infected macrophages attenuated in their capacity to
disseminate (Darghouth, 2008), which is generated by multiple
passages of infected monocytes/macrophages, which become attenu-
ated after having lost their hyper‐disseminating virulence trait (Baylis,
Megson, & Hall, 1995). Theileria‐infected leukocytes behave as trans-
formed cell lines, and as they no longer require exogenous growth or
survival factors, they can form colonies in soft agar and give rise todisseminated tumours in immuno‐compromised mice (Fell, Preston, &
Ansell, 1990; Lizundia et al., 2006). Known as the only eukaryote
pathogen to transform a eukaryote host cell, Theileria achieves this by
manipulating host cell signalling pathways, reviewed in B. Shiels et al.
(2006). Several different signalling pathways have been implicated,
including TGF‐β (Chaussepied et al., 2010; Haidar et al., 2015; Haidar,
Echebli, Ding, Kamau, & Langsley, 2015) and JNK kinase leading to con-
stitutive phosphorylation of c‐Jun and activation of AP‐1 (Adamson,
Logan, Kinnaird, Langsley, &Hall, 2000; Baylis et al., 1995; Chaussepied
et al., 1998; Lizundia et al., 2007).
Remarkably, Theileria‐induced transformation is strictly dependent
on the presence of live parasites, as the transformed host cell pheno-
type is fully reversible upon drug‐induced parasite death; drug‐treated
transformed leukocytes return to a quiescent nonactivated state and
eventually die (Dobbelaere & Heussler, 1999). Theileria‐dependent
JNK1 activity is required for survival of T. parva transformed B lym-
phocytes, as demonstrated by overexpression of a dominant negative
kinase‐dead mutant of JNK1 and/or via the use of pan‐JNK inhibitor
(pan‐JNKi; Lizundia et al., 2005, 2006). Whereas the parasite‐derived
molecular mechanism(s) underlying JNK activation is unknown,
JNK1‐mediated survival of Theileria‐transformed leukocytes has been
attributed to AP‐1‐driven expression of the anti‐apoptotic genes
Mcl‐1 and c‐IAP (Lizundia et al., 2006), and uncontrolled proliferation
is linked to AP‐1‐driven expression of transferrin receptor and cyclin
D1 (Lizundia et al., 2007).
One of the characteristics of Theileria‐transformed leukocytes is
that they display heightened oxidative stress due in part to uncon-
trolled proliferation‐related production of H2O2 (Metheni et al.,
2014; Metheni, Lombes, Bouillaud, Batteux, & Langsley, 2015). This
raises the possibility that exposure to H2O2 contributes to induction
of JNK activity, as JNK activation occurs in response to stress. Taken
together, JNK activation seems a key event in Theileria‐induced leuko-
cyte transformation, and the aim of this study was to examine
whether Theileria infection affects differentially JNK1 versus JNK2
and whether the two isoforms play similar or different roles in
parasite‐induced leukocyte transformation.2 | RESULTS
2.1 | Cytosolic localisation of JNK2 versus nuclear
localisation of JNK1 in Theileria‐infected macrophages
To understand how the two major JNK isoforms participate in
Theileria‐induced leukocyte transformation, we ascertained the
subcellular distribution of JNK1 versus JNK2 in Theileria‐infected
macrophages. JNK1 partitions into the cytosolic and nuclear
fractions, and expression levels are parasite dependent, decreasing
upon Bw720c‐induced parasite death, and this is particularly obvious
for nuclear JNK1 (Figure 1a). In contrast to JNK1, JNK2 partitions
principally in the cytosolic fraction and again levels decrease upon
Bw720c. Immunofluorescence analysis revealed JNK2 in the cytosol
decorating the intracellular macroschizont (Figure 1b), which is
highlighted with a monoclonal antibody (1C12) to T. annulata p104
(Woods et al., 2013).
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FIGURE 1 JNK2 is predominantly in the infected macrophage cytosol associated with the parasite. (a) Localisation of JNK1 and JNK2 in
Theileria‐infected macrophages treated or not with parasiticide drug BW720c. Western blot analysis of nuclear and cytosolic extracts probed
with specific JNK1, JNK2, and pan‐JNK antibodies. PARP antibodies were used to control for the specificity of the nuclear extracts. (b, top panel)
Immunofluorescence images (V) showing association of JNK2 with the parasite decorated with a parasite monoclonal antibody (1C12) to P104. (b,
bottom panel) No immunofluorescence was observed (Vc) when just secondary antibodies were used as a negative control. JNK2/P104
colocalization was analysed by the Manders method of pixel intensity correlation measurements using ImageJ/Fiji‐Coloc2 plugin, and an average
for 30 independent cells is given. DNA was stained with DAPI (blue)
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surface JNK‐binding protein
As JNK2 appears associated with the macroschizont, we searched for
a parasite surface protein predicted to have a JNK‐binding motif
(Bogoyevitch & Kobe, 2006). In silico analyses were performed on
three different species of Theileria (T. annulata, T. parva, and Theileria
orientalis). A D‐Finder scan of the whole predicted proteomes of three
Theileria species in search of D‐motifs (Zeke et al., 2015) led to
identification of 26, 24, and 25 proteins, respectively (Supporting
Information S1). Next, we asked which of these 75 putative Theileria
JNK‐binding proteins also had a predicted signal peptide, and this
criterion identified only one protein inT. annulata (TA08425), two pro-
teins in T. parva (TP04_0437 orthologue of TA08425, and a hypothet-
ical proteinTP02_0553), and no protein inT. orientalis. TA08425 codes
for a GPI‐anchored T. annulata macroschizont surface protein calledFIGURE 2 p104 interacts with JNK2 inTheileria‐infected leukocytes. (a) Im
cell lysates derived from infected (TBL3) and noninfected B cells (BL3), with
Input shows JNK and P104 protein levels in BL3 and TBL3 cells revealed by
form V. (b, right) Immunoprecipitation with pan‐JNK, specific anti‐JNK2, a
macrophages (V) probed with 1C12. Input shows the levels of the p46 JNK1
actin antibody was used as a loading controlp104 (Woods et al., 2013), which has three putative decapeptide
D‐motifs (KNESMLRLDL, KSPKRPESLD, and KRSKSFDDLT) located
between amino acids 331–341, 606–616, and 804–814, respectively.
However, only the decapeptide motif between amino acids 804 and
814 is conserved in the T. parva p104 orthologue (TP04_0437). The
amino acid sequence in this region of p104 is not conserved in the
nontransforming T. orientalis (TOT_040000478).
We examined, therefore, whether the conserved D‐motif
(KRSKSFDDLT) mediated JNK2 binding to the T. annulata
macroschizont surface protein p104. First, a pan‐JNK antibody
precipitated endogenous p104 from extracts of T. annulata‐infected
TBL3 B cells but not from uninfected BL3 B cells (Figure 2a). As
expected (see Figure 1), p104 was preferentially found in pan‐JNK pre-
cipitates (Figure 2b, left) and specifically in JNK2 precipitates (Figure 2b,
right, and Figure 3b). Altogether, these results suggest that JNK2 is
associated with p104 at the surface of theTheileria macroschizont.munoprecipitation with a pan‐anti‐JNK (JNK‐IP) antibody using whole
the precipitate probed with the anti‐p104 monoclonal antibody 1C12.
respective antibodies. 1, BL3; 2, TBL3 1 μM; 3, IgG; 4, V; and 5, input
nd irrelevant IgG control antibodies with the precipitate from infected
and p54 JNK2 isoforms revealed with the pan‐JNK antibody. An anti‐
IP-JNK1
Input
JNK1
GAPDH
p54
p46
P104
JNK1p54p46
P104
JNK2
GAPDH
JNK2
GAPDH
IP-JNK2
Input
1 2 3 4 5 6
1 2 3 4 5 6 7 8
p54
p46
p54
p46
(a) (b)
1    2     3 4 5 6 7 1 2 3 4 5
FIGURE 3 Abrogation of JNK2/p104 interaction leads to proteasome‐mediated JNK2 degradation. Immunoprecipitation analyses with specific anti‐
JNK2 and anti‐JNK1 antibodies using whole cell lysates derived from Theileria annulata‐infected macrophages treated or not with 1 or 5 μM of the
penetrating JNK‐binding motif peptide and treated or not with MG132 (P), mutant (S > A) peptide (mP), or irrelevant peptide. (a) JNK2‐IP shows western
blot of the JNK2 precipitate probed with the anti‐p104, anti‐JNK2, and anti‐GAPDH antibodies. Bottom panel shows western blot analysis of
immunoprecipitations probed with anti‐JNK2 and anti‐GAPDH antibodies. 1, V; 2, V + P 1 μM; 3, V + P 5 μM; 4, V + P 1 μM + MG132; 5, V + P
5 μM + MG132; 6, V + mP 1 μM; 7, V + mP 5 μM; 8, IgG. (b) JNK1‐IP: Immunoprecipitation analyses with anti‐JNK1 using whole cell lysates derived
from T. annulata‐infected macrophages treated or not with 1 or 5 μM of P or mP peptides. JNK1 protein expression was decreased following the
treatment with JNK‐binding motif competitive peptide, whereas no effect was observed with the mP peptide. Bottom panel shows western blot analysis
of immunoprecipitations probed with anti‐JNK1 and anti‐GAPDH antibodies. 1, V; 2, V + P 1 μM; 3, V + P 5 μM; 4, V + mP 1 μM; 5, V + mP 5 μM; 6, IgG
4 of 12 LATRÉ DE LATÉ ET AL.2.1.2 | Phosphorylation of the JNK‐binding motif
increases the affinity of p104 for JNK2
To understand the consequences of JNK2 association with p104, we
specifically ablated their interaction. Located on the macroschizont
surface GPI‐(Glycosylphosphatidylinositol)‐anchored, p104 has been
described as being phosphorylated in vivo at several sites (Wiens
et al., 2014). We noticed that two phosphorylated residues occurred
in the conserved JNK‐binding motif, specifically phospho‐S806 and
phospho‐S808 (TA08425 numbering). Consequently, penetrating pep-
tides harbouring the conserved p104 decapeptide JNK‐binding motif
and a mutant peptide, where S806 and S808 had been replaced by ala-
nine together with an irrelevant peptide, were synthesized (Table 1).
All peptides were FITC conjugated, and penetration into
T. annulata‐infected macrophages was confirmed by immunofluores-
cence (Figure S1). The peptide (P) corresponding to the wild‐type
JNK‐binding motif was able to ablate in a dose‐dependent manner
JNK2 association with p104 (Figure 3). Importantly, the mutant
(S > A) peptide (mP) did not abrogate JNK2 binding to p104
(Figure 3a, Tracks 6 and 7), consistent with phosphorylation of S806
and/or S808 promoting p104 binding to JNK2. Following peptide‐
mediated abrogation of the JNK2/p104 complex, the level of p54
JNK2 decreased due to ubiquitination of JNK2, but no drop in JNK2TABLE 1 Synthesized peptides harbouring JNK‐binding motif
Peptides Sequences
P (peptide with conserved
JNK‐binding motif)
HVKKKKIKREIKITGKIVKLKRSKSFDDLTT
mP (mutant peptide) HVKKKKIKREIKITGKIVKLKRAKAFDDLT
IrrP (irrelevant peptide) HVKKKKIKREIKIAAGRYGRELRRMADEFH
Note. The different FITC‐labelled penetrating peptides synthesized. (P) is the
underlined. The mutant peptide (mP) has S806 and S808 changed to A806 and
to compete for JNK‐binding to p104. The JNK‐binding motif is in bold, and thelevels was observed following proteasome blockade by MG132
(Figure 3a, Tracks 4 and 5, and Figure 4a). Although peptide‐induced
complex disruption reduced JNK2 levels, no effect was observed on
cytosolic JNK1 (Figure 4b), but loss of cytosolic JNK2 led to an
increase in the amount of nuclear JNK1 (Figure 4b).2.1.3 | Protein Kinase‐A (PKA), but not c‐Jun
N‐terminal Kinase (JNK), contributes to p104
association with JNK2
Both S806 and S808 in p104 occur in a context (KRS*KS*FD) consis-
tent with them being potentially phosphorylated by PKA (Wiens et al.,
2014). Consequently, T. annulata‐infected macrophages were treated
for 2 hr with myristoylated PKI (MyrPKI) or the ATP analogue H89,
and both treatments dampened the association of p104 with JNK2
(Figure 5a). By contrast, treatment with a pan‐JNKi or a JNK2‐specific
inhibitor (JNK2i) did not alter the ability of p104 to bind JNK2
(Figure 5b). We conclude that cAMP‐dependent PKA likely phosphor-
ylates S806 and/or S808, and their phosphorylation favours binding of
p104 to bind JNK2. The kinase activity of JNK2 does not appear nec-
essary for complex formation, leaving open that JNK2 could have a
scaffold function (see below).Phospho‐epitope
Predicted kinases
phosphorylation sites
K‐(FITC) S806, S808 PKA
TK‐(FITC) Mutations of S806,
S808 in alanine
PKA
V‐K (FITC)
conserved wild‐type amino acid sequence with S806 and S808 shown
A808 (underlined). An irrelevant peptide (IrrP) used as a negative control
sequence of the fused penetrating peptide is indicated at the N‐terminus.
JNK2
Actin
p54
Input
P
MG132
+ +
+--
- -
+
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Actin H3 Histone
JNK2
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FIGURE 4 Association with p104 protects JNK2 from ubiquitination and proteosomal degradation. (a) Immunoprecipitation analyses with anti‐
JNK2 antibodies using whole cell lysates derived from virulent Theileria annulata‐infected macrophages treated or not with 5 μM of JNK‐binding
motif peptide P and treated or not with MG132. Western blot of the JNK2 precipitate probed with an anti‐ubiquitin and JNK2 antibodies. (b)
Western blot analysis of nuclear and cytosolic extracts probed with specific anti‐JNK1 and anti‐JNK2 antibodies using whole cell lysates derived
fromT. annulata‐infected macrophages treated or not with 5 μM of P and treated or not with MG132 and virulent treated with irrelevant peptide.
Actin and H3 histone antibodies were used as loading control. Input (a), JNK2 levels in the extracts were estimated compared with actin levels
used as loading control. (b) JNK1 and JNK2 levels in nuclear extracts were compared with histone H3 levels
LATRÉ DE LATÉ ET AL. 5 of 122.2 | Abrogation of JNK2/p104 association reduces
matrigel traversal of Theileria‐transformed
macrophages
Matrigel traversal is used as a measure of dissemination potential and
virulent (V) T. annulata‐transformed macrophages traverse matrigel
better than attenuated (A) macrophages. Matrigel transversal is signifi-
cantly decreased when T. annulata‐transformed macrophages are
treated with the wild‐type JNK‐binding motif peptide (P), whereas the
(S > A) mutant peptidemP and the irrelevant peptide (irrP) had no signif-
icant effect (Figure 6a). It is well established that Theileria‐infected
macrophages are characterized by AP‐1‐driven transcription of mmp9
and increased matrix metallopeptidase 9 (MMP9) activity promotes
matrigel traversal and dissemination (Adamson et al., 2000; Cock‐Rada
et al., 2012; Echebli et al., 2014). JNK2 association with p104 was
therefore ablated, and loss of MMP9 activity was revealed by gelatin
gel assay (Figure 6b, left). Peptide‐induced disruption of JNK2/p104
binding slightly but significantly inhibited mmp9 transcription as
estimated by qRT‐PCR (Figure 6b, right). Peptide‐induced complex dis-
sociation also specifically reduced nuclear c‐Jun phosphorylation
(Figure 6c) consistent with the drop in nuclear JNK1 levels (Figure 4b).2.3 | Abrogation of the JNK2/p104 association leads
to up‐regulation of ARF levels
Because a nonkinase scaffold protein function for JNK2 has been
described to regulate smARF levels and induce autophagy (Zhang
et al., 2015a), we monitored ARF levels following disruption of the
p104/JNK2 complex and subsequent JNK2 degradation (Figure 7). Loss
of JNK2 provoked by peptide treatment resulted in up‐regulation of
p14ARF. The rise in ARF levels was accompanied with an increase in
amount of processed autophagosome membrane protein LC3B‐II and
appearance of LC3B‐II‐positive foci (Figure 7a, bottom panel, and b).3 | DISCUSSION
Constitutively active JNK1 has a nuclear localisation that is dependent
on live T. annulata macroschizonts, because nuclear JNK1 levels were
ablated upon drug (Bw720c)‐induced parasite death. By contrast,
JNK2 is mainly in the infected macrophage cytosol associated with
the macroschizont with only a minor fraction of JNK2 being nuclear,
and cytosolic JNK2 levels also depend on the live parasite being
FIGURE 5 PKA phosphorylation increases association of p104 with JNK2. (a) Immunoprecipitation analyses with an anti‐JNK2 antibody using
whole cell lysates derived from virulent Theileria annulata‐infected macrophages treated or not with the PKA specific inhibitor myristoylated
PKI (MyrPKI) and H89. Left panel shows western blot of the JNK2 precipitate from nontreated, or MyrPKI/H89 treated (+) cells probed with the
anti‐p104 1C12 monoclonal antibody. Middle and right panels show the input levels of p104 and actin revealed by their respective antibodies. (b)
Left panel: Western blot of JNK2 precipitates using extracts of cells treated with a pan‐JNK inhibitor (pan‐JNKi), or a JNK2‐specific inhibitor
(JNK2i) probed with the anti‐p104 1C12 monoclonal antibody. Right panel shows the input levels of p104 and the two JNK isoforms revealed by
their respective antibodies
6 of 12 LATRÉ DE LATÉ ET AL.present (Figure 1). Simply by their different subcellular localisations,
one can surmise that JNK1 and JNK2 likely play different roles in
Theileria‐induced transformation of host leukocytes.
The close association between JNK2 and the parasite revealed by
immunofluorescence led us to search for a parasite‐encoded
JNK‐binding protein located on the macroschizont surface. Interrogat-
ing the predicted Theileria proteomes with a consensus D‐motif
revealed the presence of three potential JNK‐binding motifs in the
GPI‐anchored macroschizont T. annulata protein known as p104
(Woods et al., 2013). We decided to characterize the putative
JNK‐binding site located between amino acids 804 and 814, as this
is conserved in the T. parva p104 orthologue (TP04_0437) and absent
in the nontransforming T. orientalis (TOT_040000478) protein.
Although not characterized here, it remains possible that one or both
of the other two T. annulata p104‐specific D‐motifs might also
contribute to species‐specific JNK2 binding by p104. In vitro recombi-
nant T. annulata p104 clearly binds to recombinant JNK2 (Figure S2A),
making it possible to study the contribution of the two other D‐motifs
to species‐specific JNK2 binding. We note that a secreted T. annulata
protein called Ta9 is predicted to contain a D‐motif and can activate
AP‐1‐driven transcription in HEK293T cells, but whether Ta9 does
this in T. annulata‐infected macrophages by binding to JNK was not
demonstrated (Unlu et al., 2018).
The conserved JNK‐binding motif in p104 is distal to the previ-
ously described EB1‐binding motif (SKIP) that is located between
amino acids 566 and 569 (Woods et al., 2013). It is highly unlikely
therefore that the JNK‐binding motif penetrating peptide competes
for EB1‐binding. Furthermore, EB1 colocalizes with p104 on the
macroschizont surface in a cell cycle‐dependent manner, being more
pronounced during cell division (Woods et al., 2013). This contrastswith JNK2‐binding to p104 that does not require division of infected
macrophages. Although p104 acts as an EB1‐binding protein, attempts
to interfere with EB1 binding to the macroschizont surface failed
(Woods et al., 2013). One explanation could be that JNK2 binding to
p104 creates a platform favourable to EB1 association with the
macroschizont during host cell mitosis. As we have shown that PKA
can phosphorylate in vitro p104 (Figure S2B), this strongly argues that
in vivo PKA‐mediated phosphorylation of p104 (Wiens et al., 2014)
promotes association with JNK2, and indeed, PKA inhibition reduced
the amount of p104 detected in JNK2 immunoprecipitates
(Figure 5). This implies that the complex at the surface of the
macroschizont contains not only p104 and JNK2 but also PKA. By
contrast, Cdk1‐mediated phosphorylation of p104 seems to play a role
in EB1 binding during mitosis, although the role of other kinases in
regulating the interaction between p104 and EB1 has not been ruled
out (Woods et al., 2013).
Importantly, both S806 and S808 have previously described as
being phosphorylated in vivo (Wiens et al., 2014), so the strategy
we adopted to elucidate the role of the JNK2/p104 complex was
to use a penetrating peptide harbouring the conserved JNK‐binding
motif, as a competitive p104 substrate for PKA. When S806 and
S808 are changed to A806 and A808, the mutant penetrating pep-
tide is no longer a competitive substrate for PKA and is incapable
of disrupting JNK2 binding to p104. It is noteworthy that binding
of JNK2 to p104 in vivo was disrupted by inhibition of PKA
activity by two independent PKA inhibitors, MyrPKI and H89. Inter-
estingly, however, recruitment of JNK2 to p104 was insensitive to
inhibition of JNK kinase activity, suggesting JNK2 acts as a scaffold
protein on which the complex is assembled at the macroschizont
surface.
FIGURE 6 Peptide‐provoked disruption of the JNK2/p104 complex diminishes matrigel traversal of T. annulata‐transformed macrophages. (a)
Upper panel: Matrigel traversal of virulent (V) compared with attenuated (a) macrophages and virulent macrophages treated with the JNK‐
motif penetrating peptide, the mutant (S > A) peptide (mP), or control irrelevant peptides (irrP). Peptide (P)‐provoked disruption of the JNK2/p104
complex reduced matrigel traversal of virulent macrophages (V + P) to below attenuated levels, whereas treatment of virulent macrophages with
the mutant (S > A) peptide (V + mP) or control peptide (irrP) had no effect. (b, left panel) Zymogram showing MMP9 activity in the supernatants of
virulent (V) compared with attenuated (a) macrophages and virulent macrophages treated with the competitive JNK2‐binding peptide (P). (Right
panel) Relative expression of mmp9 in virulent and attenuated Theileria‐infected treated or not with the competitive JNK‐binding peptide (P), or
the mutant (S > A) peptide (mP). (c, upper panel) Nuclear c‐Jun phosphorylation displayed by virulent macrophages treated or not with the
competitive JNK‐binding peptide (P), the mutant (S > A) peptide (mP), or control peptides (irrP). Scale bar is equivalent to 10 μm. (Bottom panel)
Percentage of corrected total cell fluorescence due to phospho‐Ser73‐c‐Jun staining based on 30 independent cell images. All experiments were
done independently (n = 3). The error bars show SEM values from three biological replicates, *p value < 0.05, ***p value < 0.001
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physiological advantage to Theileria‐induced leukocyte transformation
in retaining JNK2 in the infected host cell cytosol sequestered at the
macroschizont surface. The ensembles of our results pinpoint at least
three advantageous consequences of p104‐mediated JNK2 sequestra-
tion: (a) While associated with the macroschizont surface, JNK2 is
protected from ubiquitination and proteasomal degradation, and
sustained JNK2 levels suppress smARF‐mediated autophagy
(Budina‐Kolomets et al., 2013; Zhang et al., 2015b). As such, JNK2
sequestration contributes to Theileria‐infected leukocyte survival; and
indeed, 24 hr following peptide‐induced JNK2 degradation, infected
macrophages become annexin V positive (Figure S3). (b) As nuclear
JNK2 decreases c‐Jun stability by promoting its ubiquitination (Bode
& Dong, 2007; Fuchs et al., 1996), cytosolic retention of JNK2 could
contribute to sustained nuclear c‐Jun levels perhaps by preventing
DET1‐mediated ubiquitination (Marsolier et al., 2013). Sustaining
c‐Jun levels also occurs via secretion of a parasite prolyl isomerase
called TaPIN1 that provokes degradation of the host ubiquitin ligase
FBW7 (Marsolier et al., 2015). (c) Now, we show that peptide‐inducedcomplex dissociation led to JNK2 ubiquitination and degradation and
a loss of nuclear c‐Jun fluorescence (Figure 6c). Moreover, upon loss
of cytosolic JNK2, the nuclear levels of JNK1 also decrease, suggesting
an alternative reason for loss of c‐Jun phosphorylation (Figure 4b).
Dampening of nuclear JNK1 levels also likely explains the drop in
mmp9 transcription and reduced matrigel traversal (Figure 6). Targeting
JNK to c‐Jun signalling is clearly a key part of the T. annulata‐induced
transformation process that involves bothmanipulating JNK (this study)
and c‐Jun levels (Marsolier et al., 2013, 2015).
The macroschizont surface of T. annulata‐infected macrophages is
known to recruit another host cell tumour suppressor p53, preventing
its translocation to the nucleus, inhibiting p53‐mediated apoptosis,
and thus contributing to host cell survival (Haller et al., 2010). More-
over, ARF participates in the regulation of p53 interaction with
MDM2 (Maggi et al., 2014; Trino et al., 2016; Vivo et al., 2015). It is
interesting to note that antisense knockdown of jnk2 has been
described to dampen phosphorylation of p53 (Buschmann et al.,
2001), making it possible that p53 is a substrate of JNK2 at the
macroschizont surface in Theileria‐infected leukocytes. It remains to
ARFp14
GAPDH
1 2 3
LC3B-II
Actin
(a) (b)
1 2 3 4 DAPIMerge
V+P
V
Vc
V+mP
LC3B-II
FIGURE 7 Loss of JNK2 provokes appearance of smARF and induction of autophagy. (a) Loss of JNK2 provoked by treating virulent
macrophages (Lane 1) with 1 μM (Lane 2) and 5 μM (Lane 3) of the penetrating JNK‐binding motif peptide causes a dose‐dependent increase
in the amount of p14 ARF. No effect was observed with 5 μM of mutant peptide (Lane 4). (Bottom) Virulent macrophages (Lane 1) were treated or
not with 5 μM of penetrating JNK‐binding motif peptide (Lane 2) and cell extracts probed with the specific LC3B‐II antibody; 5 μM peptide
treatment results in augmented amount of processed LC3B‐II. No effect was observed with 5 μM of mP (Lane 3). (b) Immunofluorescence images
obtained with anti‐LC3B‐II antibody using virulent (V) macrophages treated or not with JNK‐binding motif peptide (P), or mutant peptide (mP).
Only in peptide treated (V + P) macrophages is an augmentation in LC3B‐II and clustering of LC3B‐II‐positive structures evident. No fluorescence
was observed with Alexa‐labelled secondary antibody (Vc). Scale bar is equivalent to 10 μm. (Bottom) Percentage of corrected total cell
fluorescence due to LC3B‐II staining based on 25 independent cell images. All experiments were done independently (n = 3). The error bars show
SEM values from three biological replicates. **p value < 0.01
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(Heussler et al., 2002) also involves binding to JNK2/p104, or because
the number of parasite‐associated IKK signalosomes fluctuates in the
course of the host cell cycle, binding occurs indirectly perhaps via
EB1, or other cytoskeleton‐associated proteins.
Infection by another apicomplexan parasite Toxoplasma gondii
leads to constitutive activation of a MAP/SAP kinase called p38
(Braun et al., 2013). This contrasts with Theileria, wherein different
types of leukocytes transformed either by T. annulata or T. parva infec-
tion lead to constitutive activation of JNK rather than p38 (Botteron &
Dobbelaere, 1998; Chaussepied et al., 1998; Galley et al., 1997). Just
why JNK2, and not JNK1, binds to p104 in vivo is not clear, because
the JNK‐binding motifs identified in p104 do not, in principle, discrim-
inate between JNK isoforms. One possibility is that in vivo
PKA‐mediated phosphorylation of the conserved D‐motif renders it
more specific for JNK2 over JNK1. The T. gondii p38‐binding protein
harbours two MAP‐kinase binding motifs, called KIM1 and KIM2 for
kinase interaction motifs (also known as D‐motifs), which occur in a
disordered C‐terminal repetitive region of GR24 (Pellegrini et al.,
2017). Although the MAP‐kinase binding sites in p104 and GRA24
fit the same loose D‐motif consensus, their amino acid sequences
are different. The two D‐motifs present in GRA24 combine to provoke
high‐affinity binding of p38, whereas we posit that PKA‐mediated
phosphorylation of S806 and S808 in p104 promotes binding to
JNK2. It is remarkable that these two pathogenic Apicomplexa both
manipulate host cell MAP/SAP kinase signalling but do so in different
ways. Secreted GR24 goes into the host cell nucleus and binds and
activates p38, whereas GPI‐anchored p104 expressed on the
macroschizont surface binds JNK2, preventing it from translocating
to the nucleus, whereas activated JNK1 goes to the nucleus andphosphorylates c‐Jun to drive mmp9 transcription. Clearly, the need
for a better understanding of both kinase and nonkinase, scaffold‐like
functions of JNK2 bound to p104 will animate future studies aimed at
dissecting Theileria‐induced leukocyte transformation.
In conclusion, Theileria parasites infect and transform their host
bovine leukocytes into tumour‐like cells that disseminate throughout
infected animals, causing a widespread disease called tropical
theileriosis. Virulence has been ascribed to the parasite's ability to
constitutively activate leukocyte JNK leading to permanent induction
of MMP9 that promotes transformed macrophage dissemination.
However, in leukocytes, JNK exists as two isoforms, JNK1 and
JNK2; and we have shown that in Theileria‐transformed macrophages,
they have different subcellular localisations and perform separate
functions. Surprisingly, JNK2 associates with the parasite and is not
in the nucleus like JNK1. JNK2 is hijacked by the parasite via binding
to a macroschizont surface protein called p104, and upon forced
complex dissociation, JNK2 gets degraded, and its loss negatively
affects infected macrophage survival and ability to disseminate.4 | EXPERIMENTAL PROCEDURES
4.1 | Chemicals and reagents
Pan‐JNKi (JNK II #420128, Calbiochem, La Jolla) was added at 16 μM,
and JNK2 inhibitor (JNK IX: #420136, Calbiochem, La Jolla) was added
at 50 nM. Synthetised penetrating peptides harbouring JNK‐binding
domain were produced by GL Biochem Ltd (Shanghai, China) and
was added at 1 or 5 μM for 2 hr. MG132 (CAS 1211877‐36‐9) was
added at 10 μM for 2 hr. PKA inhibitor H89 (Sigma‐Aldrich) was added
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50 μM for 2 hr.4.2 | T. annulata‐infected macrophage culture
T. annulata‐infected monocytes/macrophages used in this study are
the Ode virulent corresponding to passage 53 (Singh et al., 2001). All
cells were incubated at 37°C with 5% CO2 in Roswell Park Memorial
Institute medium supplemented with 10% fetal bovine serum,
2 mM L‐glutamine, 100 U penicillin, 0.1 mg/ml streptomycin, and
4‐(2‐hydroxyethyl)‐1‐piperazineethanesulfonic acid (HEPES).4.3 | Analyses of JNK‐binding sites in Theileria
proteomes
We obtained the protein sequences of T. annulata, T. parva, and
T. orientalis from PiroplasmDB. We used “D‐Finder” programme, with
default settings (Whisenant et al., 2010), to scan the complete pre-
dicted proteomes of the three species in search of D‐sites (docking
site for JNK). The search was filtered with cut‐off threshold of 1e−23
as recommended (Whisenant et al., 2010). Signal peptide prediction
was done by TOPCONS (Tsirigos, Peters, Shu, Kall, & Elofsson, 2015).4.4 | Antibodies and western blot analyses
Cells were harvested and lysed by using lysis buffer (20 mM HEPES,
1% Nonidet P‐40, 0.1% SDS, 150 mM NaCl, 2 mM EDTA), phospha-
tase inhibitor cocktail tablet (PhosSTOP; Roche), and protease
inhibitor cocktail tablet (cOmplete Mini EDTA free; Roche). The
protein concentration was determined by the Bradford protein assay.
Cell lysates were subjected to western blot analysis using conven-
tional SDS‐PAGE and protein transfer onto nitrocellulose filters
(Protran and Whatman). Western blotting was performed as described
previously (Haidar, Whitworth, et al., 2015). The membrane was
blocked with a solution containing 5% of BSA and Tris‐buffered
saline–Tween for 1 hr. The anti‐T. annulata antibodies used and
diluted in the blocking solution were the 1C12 monoclonal antibody
against p104 (B. R. Shiels, McDougall, Tait, & Brown, 1986) and an
antibody to ribonucleotide reductase (Swan et al., 2003). Polyclonal
anti‐JNK (sc‐571), polyclonal anti‐JNK2 (sc‐46013), monoclonal
anti‐JNK2 (sc‐271133), monoclonal anti‐ubiquitin (sc‐271289), poly-
clonal anti‐phospho‐c‐Jun (sc‐7981), and a polyclonal anti‐p14ARF
(sc‐8340) were purchased from Santa Cruz Biotechnologies (Santa
Cruz, CA, USA), anti‐LC3B‐II (NB600‐1384) from Novus Biologicals,
the anti‐PARP antibody (ab194586) from Abcam (Abcam Plc,
Cambridge), and anti‐MMP9 (AV33090) from Sigma. After being
washed, proteins were visualised with enhanced chemiluminescence
western blotting detection reagents (Thermo Scientific) on fusion FX
(Vilber Lourmat). The β‐actin level was used as a loading control
throughout.4.5 | Immunofluorescence analysis
Ode macrophages were treated or not with peptide and fixed in buffer
containing 4% paraformaldehyde and 3% of sucrose for 15 min.
Permeabilisation was performed using 0.01% Triton in PBS medium
for 5 min followed by two washes with 1× PBS. Cells were then
blocked with 3% bovine serum albumin for 1 hr, stained with the
anti‐LC3B‐II antibody or the anti‐phospho‐c‐Jun for 120 min at room
temperature, and washed three times with buffer before incubation
with a secondary anti‐rabbit IgG antibody conjugated with,
respectively, Alexa 546 or Alexa 647 (Molecular Probes) in darkness
for 60 min at room temperature. Cells were stained with 4′,6‐
diamidino‐2‐phenylindole (bisbenzimide H 33258, Sigma) for nucleus
labelling. Dako mounting medium was used (Glostrup, Denmark). The
immunolabelled cells were examined with a Zeiss observer Z1, camera
QICAM.4.6 | Coimmunoprecipitation
T. annulata‐infected macrophages were harvested and lysed in the
lysis buffer containing 20 mM HEPES, 1% Nonidet P‐40, 0.1% SDS,
150 mM NaCl, 2 mM EDTA, phosphatase inhibitor cocktail tablet
(PhosSTOP; Roche), and protease inhibitor cocktail tablet (Complete
Mini EDTA free; Roche). The protein concentration was determined
by the Bradford protein assay. Protein‐G Dynabeads (Invitrogen) were
washed twice with 1× PBS solution. After incubation with the
antibody of interest for 2.5 hr, 500 μg of protein extracts was added
overnight. The beads were washed five times with lysis buffer supple-
mented with proteases and phosphatase inhibitors and boiled in
Laemmli buffer before performing western blotting.4.7 | Matrigel chambers assay
The invasive capacity of Theileria‐infected macrophages was assessed
in vitro using matrigel migration chambers (Lizundia et al., 2006).
Culture coat 96‐well medium BME cell invasion assay was obtained
from Culturex instructions (3482‐096‐K). After 24 hr of incubation
at 37°C, each well of the top chamber was washed once in buffer.
The top chamber was placed back on the receiver plate; 100 μl of cell
dissociation solution/Calcein AM was added to the bottom chamber
of each well and incubated at 37°C for 1 hr to fluorescently label cells,
and these were dissociated from the membrane before reading at
485‐nm excitation, 520‐nm emission using the same parameters as
the standard curve.4.8 | Zymography (gelatin gel assay)
We used 10% SDS‐PAGE containing 1% copolymerised gelatin to
detect secreted gelatinases such as MMP2 and MMP9; 5 × 106 cells
were washed three times with cold PBS to remove all the serum and
were plated in six‐well plates in 5 ml of serum‐free culture medium.
Supernatants from these cultures were collected after 24 hr. Superna-
tant samples were mixed with 2× sample buffer containing 0.5 M Tris–
HCl pH 6.8, 20% glycerol, 10% SDS, and 0.005% bromophenol blue.
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the gel. Migration was performed in 1× Tris–glycine SDS running
buffer at 125 V. The gels were washed twice for 30 min in renaturing
buffer containing 2.5% Triton X‐100, which removed the SDS. To acti-
vate the proteases, gels were incubated at 37°C for 18 hr in 30 ml of a
solution containing 50 mM Tris–HCl pH 7.6, 5 mM CaCl2, and 0.02%
Triton X‐100. Gels were subsequently stained for 2 hr with a solution
containing 0.5% Coomassie Blue R‐250, 40% methanol, 10% acetic
acid and de‐stained with 50% methanol, and 10% acetic acid. Areas
of digestion appeared as clear bands against a darkly stained back-
ground due to the substrate being degraded by the enzyme.
4.9 | RNA extraction, reverse transcription, and qRT‐
PCR
Total RNA was extracted from cells with the RNeasy® Plus mini kit
(QIAGEN) and quantified by the NanoDrop ND1000 Spectrophotom-
eter. cDNA was synthesized from 1,000 ng of RNA by using M‐MLV
reverse transcriptase enzyme (Promega). The qRT‐PCR reaction
mixture included 2.5 μl ABsolute blue qPCR SYBR green (Thermo
Scientific), 0.5 μl of each forward and reverse primers, 4 μl molecular
grade water, and 2.5 μl of 1:20 diluted cDNA.
Actin left primer: AGAGGCATCCTGACCCTCAA;
Actin right primer: TCTCCATGTCGTCCCAGTTG;
MMP9 left: TGGCACGGAGGTGTGATCTA;
MMP9 right: GACAAGAAGTGGGGCTTCTG.4.10 | GST pull downs
The C‐terminal disordered region (504‐839) of T. annulata p104 was
subcloned into a modified pET vector enabling expression of GST
fusion proteins with a C‐terminal hexa‐histidine tag by PCR. The
cDNA of full‐length human JNK2 was subcloned into another
modified pET plasmid, allowing the expression of proteins with an
N‐terminal hexa‐histidine tag. All protein constructs were expressed
in Escherichia coli Rosetta (DE) pLysS cells with standard techniques.
Protein expression was induced at 25°C for 3 hr by adding 0.2 mM
IPTG, cells were lysed, and the lysate was loaded onto Ni‐NTA resin
and eluted by imidazol. GST‐p104 samples were then loaded to
glutathione resin and washed with GST wash buffer (20 mM Tris
pH 8.0, 150 mM NaCl, 0.05% IGEPAL, 1 mM EDTA, and 5 mM
beta‐mercaptoethanol). Ni‐NTA‐eluted JNK2 was further purified by
using an ion‐exchange column (resourceQ) and was eluted with a salt
gradient (0.1–1 M NaCl). In a typical GST pull‐down experiment, 50 μl
of glutathione resin loaded with the bait was incubated in 100 μM of
JNK2 solution in GST wash buffer and washed three times. After addi-
tion of SDS loading buffer, the resin was subjected to SDS‐PAGE, and
gels were stained by Coomassie Brilliant Blue protein dye, or the gels
were subjected to western blots using anti‐His, GE Healthcare (27‐
4710‐01), or anti‐JNK, Cell Signaling (3708S), antibodies according
to the supplier's recommendations. All plasmid DNA sequences were
confirmed by sequencing. GST protein with a C‐terminalhexa‐histidine tag was used as the negative control for the GST
pull‐down experiments.
4.11 | In vitro kinase assays
The catalytic domain of PKA with an N‐terminal hexa‐histidine tag
was expressed in E. coli using the pET15b PKA Cat vector (Narayana,
Cox, Shaltiel, Taylor, & Xuong, 1997) and purified with Ni‐NTA resin
similarly as described above; 0.5 μM PKA catalytic subunit was incu-
bated with 5 μM GST or GST‐p104 C‐terminal disordered region
(504‐839) fusion protein in the presence of radioactively labelled
ATP(γ)P32 (~5 μCi). Aliquots of the kinase reactions were taken at
different time points and run on SDS‐PAGE. Gels were mounted onto
filter paper, dried, and subjected to phosphoimaging using a Typhoon
Trio+ scanner (GE Healthcare). The kinase buffer contained 20 mM
Tris pH 8.0, 100 mM NaCl, 0.05% IGEPAL, 5% glycerol, 2 mM TCEP,
5 mM MgCl2, and 0.25 mM ATP.
4.12 | Flow cytometry
Infected macrophages were treated with 5 μM of nonconstrained
CCP; 106 Ode cells are prepared in 1 ml of PBS with 10% fetal bovine
serum in each test tube. After a centrifugation for 5 min at 200 × g and
4°C, cells are resuspended in 100 μl annexin V binding buffer; 5 μl of
annexin V and 5 μl of 7AAD (7‐aminoactinomycin D) are added to
each tube except a single stained control. Ode cells are incubated
for 15 min in the dark at room temperature with 400 μl ice‐cold
annexin V binding buffer and then analysed on the flow cytometry
(Accuri C6‐C flow Plus software).
4.13 | Statistical analysis
Experiments were performed at least three times, and results are
presented as mean values ± SEM. p values were determined using
Student's t test. Results were considered significant for p < 0.05.
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